Cargando…
Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis
SIMPLE SUMMARY: Rates of early-onset colorectal cancer (eoCRC), defined as <50 years of age at diagnosis, have increased. Nearly one-quarter of cases of eoCRC may be associated with a germline pathogenic variant (PGV) resulting in a hereditary cancer syndrome. In the present study, we reviewed pa...
Autores principales: | Storandt, Michael H., Rogen, Kara R., Iyyangar, Anushka, Schnell, Rylie R., Mitchell, Jessica L., Hubbard, Joleen M., Sinicrope, Frank A., Jatoi, Aminah, Mahipal, Amit, Shi, Qian, Jin, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377669/ https://www.ncbi.nlm.nih.gov/pubmed/37509234 http://dx.doi.org/10.3390/cancers15143570 |
Ejemplares similares
-
Gastrointestinal perforation after bevacizumab: a multi-site, single-institution study with a focus on survival
por: Storandt, Michael H., et al.
Publicado: (2023) -
Targeted Therapies in Advanced Cholangiocarcinoma
por: Storandt, Michael H., et al.
Publicado: (2023) -
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations
por: Storandt, Michael H, et al.
Publicado: (2022) -
A randomized, double-blinded feasibility trial of educational materials for hiccups in chemotherapy-treated patients with cancer
por: Ehret, Christopher J., et al.
Publicado: (2022) -
Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study
por: Palmer, Mathias E., et al.
Publicado: (2023)